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Transporting Clinical Research to Community Settings: Designing and  
Conducting a Multisite Trial of Brief Strategic Family Therapy
T
his paper describes the development and implementation of a trial of Brief Strategic Family Therapy (BSFT), an evidence-
based drug intervention for adolescents, in eight community substance abuse treatment programs. Researchers and treat-
ment programs collaborated closely to identify and overcome challenges, many of them related to achieving results that were 
both scientifically rigorous and applicable to the widest possible variety of adolescent substance abuse treatment programs. To 
meet these challenges, the collaborative team drew on lessons and practices from efficacy, effectiveness, and implementation 
research.
B
rief Strategic Family Therapy (BSFT) is an evidence-based treatment 
(EBT) that addresses family relationships associated with adolescent 
drug use (Szapocznik, Hervis, and Schwartz, 2003). BSFT has been 
shown to be efficacious in reducing adolescent drug use and conduct problems 
and in improving family functioning overall (Santisteban et al., 2003; Szapocznik 
et al., 1983; Szapocznik et al., 1986; Szapocznik et al., 1988). Here we describe 
the implementation of a multisite trial to determine whether BSFT can be effec-
tive in the community-based programs where adolescent drug abusers typically 
receive treatment.
We focus on the study design and protocol adjustments that we devised to 
meet two challenges that are common to all attempts to evaluate EBTs in com-
munity settings:
• to produce results that combine scientific rigor with validity for the range of 
community programs that treat the types of patients that the intervention is 
designed to help;
•   to address the complex interplay between therapists, the interventions they deliver, 
and the service-delivery contexts into which interventions are to be implemented 
(Aarons and Sawitzky, 2006; Backer, 2000; Ducharme et al., 2007; Henderson, 
MacKay, and Peterson-Badali, 2006; Simpson, 2002).
The requirement to achieve both rigor and broad validity has led to the develop-
ment of hybrid research designs. Such designs combine features typically associated 
with efficacy studies, which measure benefits in a research setting, with criteria of 
effectiveness research, which assesses the impact of interventions in communitysettings. As is typical of such designs, our study sought 
to preserve the integrity of treatment comparisons by 
including intensive therapist training and supervision 
and well-developed procedures for assessing fidelity to 
interventions, while enhancing the generalizability of 
findings by enrolling a heterogeneous patient sample 
that reflects those typically seen in community programs 
(Carroll and Rounsaville, 2003; Clarke, 1995; Schoen-
wald and Hoagwood, 2001).
The need to consider the service-delivery environ-
ment has given rise to implementation research, which 
focuses on the modifications to interventions and adjust-
ments to service-delivery systems that affect success in 
community settings. The community programs in our 
study made a number of such adjustments, including, for 
example, altering their normal procedures for training 
therapists and for billing.
We hope that this account of our experience will 
help researchers and community programs prepare for 
collaborative effectiveness studies by providing examples 
of issues that may arise and one group’s solutions. Some 
of the strategies we describe are relevant to implementa-
tion research in general. Others are particularly suitable 
for studies of family-based treatments of adolescent drug 
abuse (Dennis et al., 2004; Henggeler, 2004; Liddle et 
al., 2006; Schoenwald, Brown, and Henggeler, 2000).
StUDy overview
The BSFT effectiveness study was a collaboration 
between the clinical research faculty at the University 
of Miami Center for Family Studies, where BSFT was 
developed and its efficacy established, and the Clinical 
Trials Network (CTN) of the National Institute on Drug 
Abuse. The CTN is a consortium of a Federal funding 
agency, treatment researchers, and community-based 
treatment agencies that was formed to implement and 
test EBTs in community settings (Ducharme et al., 2007; 
Marinelli-Casey, Domier, and Rawson, 2002; Reback et 
al., 2002). Our trial compared BSFT to adolescent outpa-
tient treatment as usual at eight community-based treat-
ment agencies belonging to the CTN: Arapahoe House 
(Thornton, Colorado); Crossroads Center (Cincinnati, 
Ohio); Daymark (Salisbury, North Carolina); Gateway 
Community Services, Inc. (Jacksonville, Florida); La 
Frontera Center (Tucson, Arizona); Universidad Central 
del Caribe (Bayamón, Puerto Rico); Tarzana Treatment 
Centers (Tarzana, California); and The Village South 
(Miami, Florida).
The BSFT trial is one of the largest and most complex 
evaluations of a family-based intervention for drug abuse 
to date. Participants included 480 adolescents, their fami-
lies, and other significant individuals in their lives—1,894 
individuals altogether. Seventy-five therapists took part. 
Of these, 30 were assigned to deliver BSFT, and 23 of 
these received the full BSFT clinical training.
Treatment as usual varied considerably from agency 
to agency. It might include individual, group, and fam-
ily therapy, as well as case management and psychiatric 
consultation. At one agency, it consisted of intensive 
outpatient services with several hours daily of individual 
and group therapy sessions. Because we anticipated 
variability in treatment as usual, we planned to analyze 
differences in the effects of BSFT and treatment as usual 
at each site as well as across all sites.
The primary study hypothesis was that BSFT would 
reduce adolescent drug use more than treatment as usual 
would. Secondary hypotheses were that BSFT would 
be more effective in engaging families in treatment; in 
reducing teens’ risky sexual behaviors, delinquency, and 
externalizing disorders; and in improving family func-
tioning and positive social activities. Patients’ primary 
and secondary outcomes were measured for 1 year after 
they were randomly assigned to one or the other treat-
ment. All BSFT-related treatment and assessments have 
been completed, and analysis of the data is currently 
under way. The study findings will be reported elsewhere. 
protocol Development
The first step in the trial was to establish a team to develop 
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the study protocol. Initially, representatives from the 
University of Miami’s Center for Family Studies and 
from four community agencies across the State of Florida 
made up the entire team. Over time, however, the team 
expanded to include individuals from universities and 
community agencies across the Nation. With the goal 
of obtaining the widest possible array of research and 
community viewpoints, we welcomed any professionals 
from community agencies who expressed an interest in 
developing the protocol, whether or not their agency 
planned to participate in the study. Collectively, the 
team of 12, led by BSFT developer José Szapocznik, 
had expertise in conducting clinical trials with scientific 
integrity and also in administering community-based 
treatments. 
The team’s first challenge was to determine the appro-
priate community treatment setting for examining BSFT. 
Community providers on the team considered three 
potential designs: (1) BSFT integrated into standard 
residential treatment, (2) BSFT as a followup interven-
tion for adolescents released from residential programs, 
and (3) BSFT as an outpatient intervention. The first 
design was rejected, because the trials that had estab-
lished BSFT’s efficacy had all tested it as a stand-alone 
intervention. The second and third designs were adopted.
The protocol team also had to select an appropri-
ate comparison condition. Most prior family therapy 
effectiveness studies have compared the trial intervention 
with a specific alternative treatment regimen; however, 
the results of such studies are applicable mainly to treat-
ment programs that use the particular regimen used as 
a comparison and so have limited potential impact on 
public health. The team instead adopted the commu-
nity providers’ suggestion that treatment programs and 
policymakers would be most interested in a comparison 
of BSFT with the participating programs’ treatment as 
usual. Because the programs varied in the services they 
offered substance-abusing adolescents, this approach 
would yield information about how BSFT compared 
with a broad range of services (e.g., individual, group, 
intensive day treatment, or case management) that ado-
lescents typically receive.
A design variant that had considerable appeal would 
have deployed BSFT as an add-on intervention and 
compared treatment as usual versus treatment as usual 
plus BSFT. Among its advantages, this design would 
have provided a within-site control, required no changes 
to be made to treatment as usual, omitted the need 
to randomize the therapists, and would have been the 
easiest approach to implement. However, the increased 
burden for clients and therapists (potentially double the 
number of sessions) and costs associated with providing 
two treatments would have threatened the sustainability 
of the intervention for community programs. Hence, 
the final consensus was to implement BSFT as a stand-
alone intervention.
Throughout the planning and carrying out of the 
study, the researchers and community practitioners of 
the protocol team worked together as equal partners 
rather than in a hierarchical relationship. Level partner-
ship established a basis for the team members to main-
tain effective communication throughout the project’s 
development and implementation. Communication 
occurred via weekly conference calls that included all 
collaborators, as well as weekly calls with the University 
of Miami research team and research assistants at the 
sites. Calls were dedicated to identifying problems and 
developing solutions. Changes to the research protocol 
were implemented only after they were discussed and 
a consensus achieved. These procedures are consistent 
with the components that were previously identified 
as essential for the successful dissemination of EBTs 
(Reback et al., 2002).
aSSemBlinG reSearcH teamS in  
commUnity proGramS
The first step in moving from discussion to implementa-
tion was to create a research structure at each community 
treatment program that would enable the program to 
carry out the complex study protocol. Each program 
identified a site principal investigator, a research coor-
dinator, and research assistants. Four programs already 
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clinical trials: They could use their existing personnel 
and organizational structures and, as one research coor-
dinator noted, they “did not need to sell the importance 
of the study to anyone on the project team.” The other 
four sites had to create new research infrastructures and 
educate their staff concerning what research involves and 
its value. In the end, the advantage enjoyed by sites with 
research experience was relative: The scope and complex-
ity of the BSFT trial—as illustrated, for example, by its 
use of 14 different assent/consent forms—was daunting 
for even the most research-savvy agencies. Although sites 
varied in how quickly they integrated new procedures 
into their daily activities, ultimately they all successfully 
implemented the research protocol and contributed data 
that were used in the final analysis. 
The principal investigator at each agency was respon-
sible for onsite monitoring and oversight of the study 
protocol. Among the challenges principal investigators 
addressed during the trial were coping with competition 
among different agency programs for new clients, nego-
tiating BSFT protocol demands versus agency therapist 
productivity pressures (e.g., number of hours billed and 
completion of paperwork), securing adequate funding 
and other resources for both study implementation and 
agency clinical services, and promoting the benefits of the 
project to all involved agency departments. The principal 
investigator became the most important factor determin-
ing each program’s degree of success in implementing 
the protocol. In general, the more involved the principal 
investigator was with the daily activities of the protocol, 
the more quickly the program identified potential prob-
lems and developed solutions. Similarly, the stronger his 
or her leadership position was before the study, the more 
successful the site was in overcoming barriers. 
Research assistants were critical to the protocol’s 
success as well. They helped to recruit participants, con-
duct assessments, and relay completed measures to data 
management. The protocol team encouraged sites to hire 
research assistants who were proficient in attending to 
the details of research forms and procedures but could 
also engage and interact simultaneously with several 
family members, some of whom had serious mental or 
behavioral problems or were at odds with each other. 
Another goal in recruiting research assistants was to find 
individuals who possessed a specific set of clinical skills 
that included communicating enthusiasm about treat-
ment and the study, listening and validating each person’s 
concerns, working around family conflicts, and providing 
appropriate care in chaotic home environments. The 
assistants would have to overcome considerable client 
ambivalence and resistance because adolescents and 
their families typically do not see themselves as being 
in need of change.
tHerapiSt Selection
Community treatment programs that have training slots 
available—whether for BSFT, another family therapy, 
or other interventions—generally offer them to their 
“best” or most appropriate clinicians. Doing so enables 
the programs to obtain the maximum benefit from their 
investments in training. We were concerned, however, 
that if the community programs in our study selected 
their most skilled clinicians to learn and deliver BSFT, 
our results would be biased in favor of BSFT. To prevent 
this, the study conducted formal assessments of agency 
clinicians’ interpersonal skills, willingness to partici-
pate in intensive training, and other factors necessary 
to provide treatment as usual and to learn BSFT. Only 
therapists whose scores on these assessments demon-
strated aptitude for both interventions were accepted 
into the study. We assigned these therapists randomly 
to either receive training and deliver BSFT or provide 
treatment as usual. By randomizing their assignments, 
we ensured that the range of aptitudes was similar among 
the therapists in both treatment groups.
Some participating agencies’ adolescent outpatient 
departments were too small to supply the minimum of 
four therapists that we needed to be able to distinguish 
BSFT effects from therapist effects independently at 
each study site. To make up the difference, these agen-
cies recruited volunteers who worked in other depart-
ments or in the community, or who had not previously 
treated adolescents with substance abuse problems. This 
liberal approach should enhance the generalizability of 
our results to programs whose therapists may have less 
experience treating adolescent substance abuse. Because 
of it, our study results may suggest how much therapists 
with a wide range of skill levels can achieve with BSFT, 
while underrepresenting what programs that follow 
normal practices for therapist selection and training 
might achieve.
When a site recruited therapists who were not from 
its adolescent outpatient department into the study, its 
principal investigator had to reorganize staff to meet both 
the agency’s contractual obligations and the requirements 
of the protocol. For example, the protocol required 
BSFT therapists to devote approximately 20 percent of 
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a full-time work week to BSFT training, supervision, 
and study-related paperwork. Some agencies could draw 
from a pool of part-time staff to fill the personnel gaps 
created by this shift in BSFT therapists’ responsibilities. 
However, the allocation of time to the research pro-
tocol presented a major challenge to agencies whose 
clinical staff were already spread thin covering existing 
obligations. When therapists added BSFT training to 
their full existing caseloads, their workloads became 
unmanageable, and this impeded implementation of 
the intervention.
tHerapiSt traininG
The BSFT training process evolved over the course of 
the project in response to challenges faced by the thera-
pists. At the beginning of the trial, we provided therapist 
training as specified in the protocol:
•  a 4-day workshop consisting of a 3-day overview of 
BSFT and 1 day of training on research forms and 
study procedures;
•  three additional 1-day workshops over the next 13 
weeks;
•  weekly group supervision sessions delivered in 3-hour 
conference calls with a certified BSFT trainer/supervi-
sor at the University of Miami. 
However, high rates of therapist turnover at all the 
sites forced us to adapt and condense the training pro-
gram for replacements so that they could be deployed 
promptly. For example, a trainer traveled to one agency 
and delivered the first and second workshops back-to-
back and then returned a month later to give the third 
and fourth workshops back-to-back.
Therapist training times during the study ranged 
from 4 to 12 months. Some of the variability represents a 
downside of our “open” therapist selection process. The 
length of training was burdensome to the community 
treatment programs because every delay in certifying 
therapists translated into delays in other research activi-
ties. We originally estimated that we would require 6 
months to train the study therapists, and we scheduled 
the shorter research assistant training to begin later and 
end simultaneously, at which time we would also begin 
enrolling study participants. At the first four sites, how-
ever, therapist training took longer than anticipated, and 
programs ended up retaining research assistants while 
they waited for the therapists to attain certification. This 
had direct implications for the budget, and research 
assistants’ newly learned skills may have atrophied during 
the long wait to put them into practice. Despite these 
experiences, therapists successfully implemented BSFT 
in a manner consistent with the theoretical underpin-
nings of the therapy. Independent ratings of therapy 
sessions revealed that the therapists adhered to the core 
techniques of BSFT. They also, however, documented 
substantial variability in the quality of therapy sessions 
across therapists and even for the same therapist between 
cases and over time. This finding is consistent with our 
own observations, during supervision, that therapists 
waxed and waned in the quality of sessions. Thus, as 
other research teams have substantiated (Henggeler et 
al., 2002), adherence to systemic family therapies may 
be difficult to maintain in community agencies without 
intensive monitoring and supervision. Another indica-
tor of therapist effectiveness was that client and family 
engagement and retention rates were similar to those in 
a recent BSFT efficacy trial (Santisteban et al., 2003).
patient Selection anD recrUitment
We set patient inclusion and exclusion criteria to include 
most of the adolescents referred for drug abuse treatment 
at the participating community agencies. For example, 
we accepted youths who had used illicit drugs in the 30 
days preceding baseline assessment even if they did not 
meet diagnostic criteria for drug abuse or dependence, 
as had been required for participation in the efficacy 
trials. After we launched the protocol, we learned that 
many youths were being excluded because they had been 
referred from residential treatment settings or juvenile 
detention facilities where they did not have opportunities 
to use drugs, and we expanded our criteria to include 
these adolescents. To account for differences in the level 
of use for youths being referred from restricted settings, 
we included “referral for drug treatment from an institu-
tion” as a covariate in planned analyses. In other ways 
as well, we redesigned our analyses of drug outcomes in 
response to the considerable variability in baseline drug 
abuse among youths referred to outpatient services in 
community settings.
In another departure from the inclusion and exclu-
sion standards of the efficacy trial, we did not take into 
account co-occurring psychiatric disorders. Conse-
quently, our sample included youths with a mix of co-
occurring psychiatric disorders, which is representative 
of most community programs.
The most important factor for successful partici-
pant recruitment was the systematic integration of the 
protocol into the community agencies’ existing intake 
procedures. We recommended that the research staff 
therapists 
successfully 
implemented 
BSft in a  
manner con-
sistent with 
the theoretical 
underpinnings 
of the therapy.conduct or at least attend all intake interviews to ensure 
that every potential participant who entered the agency 
received information about the study. We observed that 
research staff who were committed to the study were most 
successful in engaging adolescents and family members 
into the protocol.
Most agencies, we found, did not highlight family 
services among the constellation of services provided, 
even though all eight considered family therapy a critical 
component of their treatment of adolescents. Work-
ing closely with each site’s principal investigator, we 
developed a strategic plan that included integrating the 
presentation of family services into the initial discus-
sions with potential participants. This approach helped 
promote the agency, as well as the study, to each family. 
Principal investigators also helped to convey the emphasis 
on family involvement to agency staff.
Court mandates provided an important referral 
stream of adolescents for many of the agencies. How-
ever, the courts sometimes required much more stringent 
treatment parameters than BSFT uses. For example, the 
court that sent adolescents to one agency usually recom-
mended one of two programs: three treatment sessions 
per week for 6 months or an intensive program of five 
sessions per week for 1 year. In this instance, the site 
principal investigator met with the primary referring 
judge to present BSFT as a viable treatment alternative. 
He highlighted the national study, the voluntary nature 
of participation, the research showing that family therapy 
was an efficacious treatment for drug-using adolescents, 
and the lack of evidence that intensive interventions 
are more efficacious than less intensive ones. The judge 
agreed to permit court-referred cases to be enrolled in 
the study. 
aGency accommoDation of reSearcH 
anD BSft
The community treatment programs had to adjust 
various practices to integrate BSFT into their service 
offerings. Although many changes were logistical and 
concrete in nature, such as securing the equipment and 
room for group supervision conference calls, others 
involved a philosophical shift. 
Strengthening the family focus
Although all the agencies acknowledged the importance 
of family involvement in the treatment of adolescents, 
most had few clinical staff with training, or even experi-
ence, working with families. Treatment as usual typi-
cally consisted of individual and group therapy; even 
when parents participated, the treatment models tended 
to be cognitive and behavioral rather than focused on 
family systems. This lack of orientation to family led 
to challenges in several areas of the project, including 
recruitment of families into the study.
To address this issue, the research team at the Uni-
versity of Miami worked with sites individually to elicit 
their views on the role of families in the treatment of 
drug-using adolescents. At several sites, the principal 
investigator expressed strong agency commitment to 
involving families in treatment, but admissions staff did 
not always communicate this to families being recruited 
for the study. Consequently, many parents opted not to 
participate based on the misunderstanding that the treat-
ment as usual did not require family involvement. This 
was particularly the case for families experiencing high 
levels of conflict and families that viewed the adolescent 
as the primary problem. To remedy this situation, site 
principal investigators were encouraged by the research 
team at the University of Miami to meet regularly with 
their admissions teams and research assistants to inform 
them about all the services, including family services, pro-
vided at the agency. These conversations were essential 
for integrating the study into the agency’s daily activities 
and convincing agency staff of the value of the research.
The early difficulty in recruiting families served as 
a warning sign. We put into place procedures to avoid 
this problem with sites that began training later and 
during the study. For example, research assistants were 
required to complete a weekly tracking list that included 
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information about all new referrals to the agency and 
an update on the research assistants’ contact with each 
of them. Members of the University of Miami research 
team reviewed this tracking list weekly.
Billing for family Services 
Clinics need to know not only whether they will be able 
to achieve desirable outcomes with a new therapy but 
also whether they can sustain it financially. Therefore, 
in contrast to efficacy trials, where the research sponsors 
typically pay for the treatment, our BSFT effectiveness 
study did not fund any clinical services. Agencies were 
reimbursed for time that therapists spent in training 
and supervision on par with the financial support that 
hundreds of national and international agencies have 
received for training and supervision in empirically based 
family therapy over the past decade through local, State, 
and Federal contracts or grants and private foundations. 
Therapists in the study received a $3,000 incentive to 
participate in training and complete research forms.
Most of the community programs in the study 
already had a standard line on their billing forms for 
family therapy, but some had to revise their procedures 
to bill for BSFT. Likewise, some agencies had to modify 
their billing practices to reimburse for family sessions in 
which the adolescent participant was not present, but 
the therapist worked with the parents on issues that 
affect the adolescent.
termination of treatment
Most community treatment pro-
grams have policies that will termi-
nate treatment of patients who miss 
sessions or violate rules. Because 
therapists carry large caseloads and 
often have waiting lists, agencies 
often close a case if the client has 
missed appointments and does not 
respond to telephone calls and a let-
ter. However, this practice is incon-
sistent with BSFT’s philosophy, 
which regards missed sessions as 
occasions for therapists to increase 
their efforts to retain and engage 
clients, if necessary, by phoning and 
conducting home visits. Agencies 
need to view these efforts as pro-
ductive, even though they may not 
receive reimbursement for client 
contacts that are not face-to-face. 
A BSFT therapist often will go to a family’s home dur-
ing the evening or on a weekend. To support this flex-
ibility, the agencies in the BSFT protocol needed to 
allow therapists to work atypical hours and reimburse 
for transportation, insurance, mileage, and other inci-
dental expenses.
Some agencies expel patients whose urine tests posi-
tive for drug use. Successful integration of the BSFT 
intervention, however, required that the community 
treatment programs in our study allow adolescents to 
remain in treatment even after numerous positive urine 
screens. Further, the research team at the University of 
Miami consulted with each site about potential BSFT 
clinical terminations, reviewing the efforts to engage 
the adolescent or family and recommending intensified 
engagement efforts when appropriate.
conclUSion
The BSFT trial was designed to evaluate the effective-
ness of an evidence-based family intervention with 
adolescent substance abusers and their families in com-
munity treatment centers. In the process of designing 
and implementing the study, key features of efficacy 
studies (e.g., intensive therapist training and ongoing 
supervision, assessment of treatment fidelity) were 
combined with features that are more characteristic 
of effectiveness research (e.g., inclusion of participants 
with co-occurring disorders, recruitment of therapists 
a BSft thera-
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